West Pharmaceutical Services ROA 2010-2023 | WST

Current and historical return on assets (ROA) values for West Pharmaceutical Services (WST) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
West Pharmaceutical Services ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2023-12-31 $0.59B $3.83B 15.84%
2023-09-30 $0.56B $3.76B 15.14%
2023-06-30 $0.52B $3.67B 14.49%
2023-03-31 $0.55B $3.72B 15.78%
2022-12-31 $0.59B $3.62B 17.28%
2022-09-30 $0.63B $3.32B 19.02%
2022-06-30 $0.69B $3.36B 20.95%
2022-03-31 $0.69B $3.30B 21.60%
2021-12-31 $0.66B $3.31B 21.83%
2021-09-30 $0.61B $3.14B 21.08%
2021-06-30 $0.52B $2.93B 18.75%
2021-03-31 $0.42B $2.74B 16.06%
2020-12-31 $0.35B $2.79B 13.78%
2020-09-30 $0.31B $2.58B 13.01%
2020-06-30 $0.29B $2.39B 12.45%
2020-03-31 $0.26B $2.25B 11.71%
2019-12-31 $0.24B $2.34B 11.11%
2019-09-30 $0.23B $2.17B 11.02%
2019-06-30 $0.23B $2.12B 11.28%
2019-03-31 $0.22B $2.04B 11.13%
2018-12-31 $0.21B $1.98B 10.80%
2018-09-30 $0.16B $1.95B 8.21%
2018-06-30 $0.15B $1.87B 8.01%
2018-03-31 $0.13B $1.87B 7.14%
2017-12-31 $0.15B $1.86B 8.20%
2017-09-30 $0.19B $1.93B 10.52%
2017-06-30 $0.18B $1.84B 10.07%
2017-03-31 $0.18B $1.73B 10.62%
2016-12-31 $0.14B $1.72B 8.44%
2016-09-30 $0.14B $1.74B 8.11%
2016-06-30 $0.10B $1.71B 6.06%
2016-03-31 $0.09B $1.67B 5.08%
2015-12-31 $0.10B $1.70B 5.80%
2015-09-30 $0.09B $1.67B 5.70%
2015-06-30 $0.12B $1.66B 7.45%
2015-03-31 $0.13B $1.60B 8.01%
2014-12-31 $0.13B $1.67B 7.52%
2014-09-30 $0.12B $1.67B 7.10%
2014-06-30 $0.12B $1.71B 6.87%
2014-03-31 $0.11B $1.71B 6.49%
2013-12-31 $0.11B $1.67B 6.93%
2013-09-30 $0.11B $1.67B 6.85%
2013-06-30 $0.10B $1.61B 6.24%
2013-03-31 $0.08B $1.58B 5.48%
2012-12-31 $0.08B $1.56B 5.39%
2012-09-30 $0.08B $1.53B 5.41%
2012-06-30 $0.08B $1.46B 5.67%
2012-03-31 $0.09B $1.46B 6.00%
2011-12-31 $0.08B $1.40B 5.45%
2011-09-30 $0.06B $1.40B 4.60%
2011-06-30 $0.06B $1.42B 4.76%
2011-03-31 $0.07B $1.37B 5.09%
2010-12-31 $0.07B $1.29B 5.21%
2010-09-30 $0.08B $1.30B 6.34%
2010-06-30 $0.08B $1.22B 6.31%
2010-03-31 $0.08B $1.25B 6.15%
2009-12-31 $0.07B $1.27B 5.88%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $28.373B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $69.513B 20.18
McKesson (MCK) United States $68.775B 18.41
Cardinal Health (CAH) United States $25.885B 15.56
Align Technology (ALGN) United States $24.450B 49.30
Cooper (COO) United States $19.104B 28.91
Labcorp (LH) United States $17.372B 14.84
Henry Schein (HSIC) United States $9.226B 15.96
DENTSPLY SIRONA (XRAY) United States $6.640B 17.50
Merit Medical Systems (MMSI) United States $4.272B 24.44
STAAR Surgical (STAA) United States $2.521B 79.39
CONMED (CNMD) United States $2.342B 22.05
Patterson (PDCO) United States $2.305B 11.04
Atrion (ATRI) United States $0.709B 36.55
Lifevantage (LFVN) United States $0.078B 12.67
Pro-Dex (PDEX) United States $0.065B 24.53
Biolase (BIOL) United States $0.005B 0.00